ONY Biotech
John Kaminski joined ONY Biotech in September 2012 as part of the Commercial Sales Team before taking on the role of National Sales Manager in 2014 and National Accounts Manager in 2017. In January of 2019, he transitioned to his current role as Director of National Accounts.
Kaminski’s sales management career has spanned 20 years with 14 of those spent focused on the surfactant market. He began his career with Medline Industries before joining the teams at Dey Pharmaceuticals and Cornerstone Therapeutics.
At ONY Biotech, Kaminski is currently responsible for all contracting and program development within the GPO and Hospital System markets.
This person is not in any offices
ONY Biotech
A small, privately-held, and family-focused neonatology pharmaceutical company, ONY Biotech is a leader in the creation of critically important products for the treatment of premature infants. They innovate with a singular purpose: to improve outcomes for premature babies and their families.